J
Joel A. Spencer
Researcher at University of California, Merced
Publications - 47
Citations - 6963
Joel A. Spencer is an academic researcher from University of California, Merced. The author has contributed to research in topics: Bone marrow & Stem cell. The author has an hindex of 23, co-authored 43 publications receiving 5884 citations. Previous affiliations of Joel A. Spencer include Harvard University & Tufts University.
Papers
More filters
Journal ArticleDOI
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto,Aditya Bardia,David T. Miyamoto,Maria C. Donaldson,Ben S. Wittner,Joel A. Spencer,Min Yu,Adam Pely,Amanda Engstrom,Huili Zhu,Brian W. Brannigan,Ravi Kapur,Shannon L. Stott,Toshi Shioda,Sridhar Ramaswamy,David T. Ting,Charles P. Lin,Mehmet Toner,Daniel A. Haber,Daniel A. Haber,Shyamala Maheswaran +20 more
TL;DR: Using mouse models with tagged mammary tumors, it is demonstrated that CTC clusters arise from oligoclonal tumor cell groupings and not from intravascular aggregation events, and though rare in the circulation, they greatly contribute to the metastatic spread of cancer.
Journal ArticleDOI
Direct measurement of local oxygen concentration in the bone marrow of live animals
Joel A. Spencer,Francesca Ferraro,Emmanuel Roussakis,Alyssa Klein,Juwell W. Wu,Judith Runnels,Walid Abbas Zaher,Luke J. Mortensen,Clemens Alt,Raphaël Turcotte,Rushdia Z. Yusuf,Daniel Côté,Sergei A. Vinogradov,David T. Scadden,Charles P. Lin +14 more
TL;DR: These pO2 values change markedly after radiation and chemotherapy, pointing to the role of stress in altering the stem cell metabolic microenvironment.
Journal ArticleDOI
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
Robert Sackstein,Jasmeen S. Merzaban,Derek W. Cain,Nilesh M. Dagia,Joel A. Spencer,Charles P. Lin,Roland Wohlgemuth +6 more
TL;DR: It is established that the HCELL glycoform of CD44 confers tropism to bone and unveil a readily translatable roadmap for programming cellular trafficking by chemical engineering of glycans on a distinct membrane glycoprotein.
Journal ArticleDOI
Endogenous Bone Marrow MSCs Are Dynamic, Fate-Restricted Participants in Bone Maintenance and Regeneration
Dongsu Park,Joel A. Spencer,Bong Ihn Koh,Tatsuya Kobayashi,Joji Fujisaki,Thomas L. Clemens,Charles P. Lin,Henry M. Kronenberg,David T. Scadden +8 more
TL;DR: Osteoblastic cells are defined as short-lived and nonreplicative, requiring replenishment from bone-marrow-derived, Mx1(+) stromal cells with "MSC" features, representing a highly dynamic and stress responsive stem/progenitor cell population of fate-restricted potential that feeds the high cell replacement demands of the adult skeleton.
Journal ArticleDOI
Distinct bone marrow blood vessels differentially regulate haematopoiesis
Tomer Itkin,Shiri Gur-Cohen,Joel A. Spencer,Amir Schajnovitz,Saravana K. Ramasamy,Anjali P. Kusumbe,Guy Ledergor,Guy Ledergor,Yookyung Jung,Idan Milo,Michael G. Poulos,Alexander Kalinkovich,Aya Ludin,Orit Kollet,Guy Shakhar,Jason M. Butler,Shahin Rafii,Ralf H. Adams,David T. Scadden,Charles P. Lin,Tsvee Lapidot +20 more
TL;DR: It is found that mammalian bone marrow stem cell maintenance and leukocyte trafficking are regulated by distinct blood vessel types with different permeability properties, and exposure to blood plasma increases bone marrow HSPC ROS levels, augmenting their migration and differentiation, while compromising their long-term repopulation and survival.